🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Several professionals said the demand for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Service Response and Material Elimination

Based on TikTok, the service has removed violative material and prohibited related hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Digital Marketplace Activities

Research also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, filled with images of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

After minutes of joining one community, a seller posted contact information, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these communities, posts show black plastic packages with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already seen individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious health risks”.